Patent · US Expired

Controlled release diamorphine formulation

US5843480A · kind A · utility

200Cited by
78References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 27, 1996
Grant dateDec 1, 1998
Priority date
Expiry dateDec 27, 2016

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/135
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A controlled-release pharmaceutical preparation comprising diamorphine, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.